Mass drug administration for malaria elimination: Do we understand the settings well enough?

BMC Medicine

Volumn 16, Issue 1, 2018, Pages

  Hetzel, Manuel W ^a,b   Genton, Blaise ^a,b,c  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Effectiveness; Low transmission; Malaria; Malaria elimination; Mass drug administration; Ongoing transmission

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ASYMPTOMATIC INFECTION; CLINICAL EVALUATION; DISEASE ASSESSMENT; DISEASE TRANSMISSION; ENDEMIC DISEASE; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; MALARIA; MALARIA CONTROL; MASS DRUG ADMINISTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SELF REPORT; TREATMENT OUTCOME; TANZANIA;

ANTIMALARIALS; HUMANS; INCIDENCE; MALARIA; MASS DRUG ADMINISTRATION; TANZANIA;

EID: 85058795428     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-018-1230-4     Document Type: Review

References (11)

1. World Health Organization (WHO). World Malaria Report 2018. Geneva: WHO; 2018.
2. Rabinovich RN, Drakeley C, Djimde AA, Hall BF, Hay SI, Hemingway J, et al. malERA: An updated research agenda for malaria elimination and eradication. PLoS Med. 2017;14:e1002456.
3. World Health Organization (WHO). Mass drug administration for falciparum malaria: a practical field manual. Geneva: WHO; 2017.
4. Hofmann NE, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M, et al. Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018;18:1108-16.
5. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
6. Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health. 2017;5:e680-7.
7. Morris U, Msellem MI, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting - high coverage and safety, but no significant impact on transmission. BMC Med. 2018. https://doi.org/10.1186/s12916-018-1202-8.
8. malERA Refresh Consultative Panel on Characterising the Reservoir and Measuring Transmission. malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication. PLoS Med. 2017;14:e1002452.
9. Le Menach A, Tatem AJ, Cohen JM, Hay SI, Randell H, Patil AP, et al. Travel risk, malaria importation and malaria transmission in Zanzibar. Sci Rep. 2011;1:93.
10. Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, Beck HP, et al. Residual antimalarials in malaria patients from Tanzania - implications on drug efficacy assessment and spread of parasite resistance. PLoS One. 2009;4:e8184.
11. Gallay J, Mosha D, Lutahakana E, Mazuguni F, Zuakulu M, Decosterd LA, et al. Appropriateness of malaria diagnosis and treatment for fever episodes according to patient history and anti-malarial blood measurement: a cross-sectional survey from Tanzania. Malar J. 2018;17:209.